FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

576711000001106: Edronax 4mg tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16816301000001118 Edronax 4mg tablets (Pfizer Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16816401000001114 Edronax 4mg tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Edronax 4mg tablets (Pfizer Ltd) Is a Product containing precisely reboxetine 4 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Is a Reboxetine 4mg tablets true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Is a Reboxetine 4mg tablets false Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Has active ingredient Reboxetine false Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Has active ingredient Reboxetine mesilate false Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Has specific active ingredient Reboxetine mesilate true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Is a Edronax true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Reboxetine false Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Has specific active ingredient Reboxetine mesilate false Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) Has basis of strength substance Reboxetine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Is pack of False Edronax 4mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has AMP True Edronax 4mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start